Table 1.
Demographics, symptomatology, and occupational exposure, PCR, seropositive and seronegative among the study participants.
| Variable | Category | n(%) |
|---|---|---|
| Age (years) | <25 | 17 (4) |
| 25–34 | 189 (45) | |
| 35–44 | 122 (29) | |
| 45–54 | 64 (15.2) | |
| 55+ | 28 (6.7) | |
| Gender | Female | 237 (57.2) |
| Male | 177 (42.8) | |
| Hospital | KSASH | 159 (37.9) |
| KAMC | 188 (44.8) | |
| PMAH | 73 (17.4) | |
| Department | ER | 89 (21.2) |
| ICU | 67 (16) | |
| Infectious disease | 33 (7.9) | |
| Respiratory Services | 20 (4.8) | |
| Internal Medicine | 106 (25.2) | |
| Paediatric | 105 (25) | |
| Job | Nurse | 189 (45) |
| Physician | 210 (50) | |
| Respiratory therapist | 21 (5) | |
| IgG antibody for SARS-CoV-2 | Seronegative | 358 (85.2) |
| Seropositive | 62 (14.8) | |
| SARS2 symptoms | Asymptomatic | 293 (69.8) |
| Symptomatic | 127 (30.2) | |
| PCR SARS-CoV-2 | Negative | 285 (67.9) |
| Positive | 31 (7.4) | |
| Not done | 104 (24.8) | |
| IgG antibody for MERS | Seronegative | 416 (99) |
| Seropositive | 4 (1) | |
| MERS PCR | Negative | 61 (14.5) |
| Positive | 0 (0) | |
| Not done | 359 (85.5) |